These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 1402387

  • 1. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes.
    Mosser DM, Handman E.
    J Leukoc Biol; 1992 Oct; 52(4):369-76. PubMed ID: 1402387
    [Abstract] [Full Text] [Related]

  • 2. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
    Davis CE, Belosevic M, Meltzer MS, Nacy CA.
    J Immunol; 1988 Jul 15; 141(2):627-35. PubMed ID: 3133412
    [Abstract] [Full Text] [Related]

  • 3. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle.
    Cooper A, Rosen H, Blackwell JM.
    Immunology; 1988 Dec 15; 65(4):511-4. PubMed ID: 3065216
    [Abstract] [Full Text] [Related]

  • 5. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
    Belosevic M, Davis CE, Meltzer MS, Nacy CA.
    J Immunol; 1988 Aug 01; 141(3):890-6. PubMed ID: 3135315
    [Abstract] [Full Text] [Related]

  • 6. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM, Edelson PJ.
    J Immunol; 1984 Mar 01; 132(3):1501-5. PubMed ID: 6363545
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan.
    Descoteaux A, Matlashewski G, Turco SJ.
    J Immunol; 1992 Nov 01; 149(9):3008-15. PubMed ID: 1383336
    [Abstract] [Full Text] [Related]

  • 8. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE.
    J Immunol; 1987 Mar 15; 138(6):1919-25. PubMed ID: 3493291
    [Abstract] [Full Text] [Related]

  • 9. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages.
    Privé C, Descoteaux A.
    Eur J Immunol; 2000 Aug 15; 30(8):2235-44. PubMed ID: 10940915
    [Abstract] [Full Text] [Related]

  • 10. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
    Mosser DM, Edelson PJ.
    J Immunol; 1985 Oct 15; 135(4):2785-9. PubMed ID: 3161950
    [Abstract] [Full Text] [Related]

  • 11. Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages.
    Koutsoni O, Barhoumi M, Guizani I, Dotsika E.
    PLoS One; 2014 Oct 15; 9(5):e97319. PubMed ID: 24830439
    [Abstract] [Full Text] [Related]

  • 12. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18).
    Mosser DM, Springer TA, Diamond MS.
    J Cell Biol; 1992 Jan 15; 116(2):511-20. PubMed ID: 1730765
    [Abstract] [Full Text] [Related]

  • 13. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages.
    Flandin JF, Chano F, Descoteaux A.
    Eur J Immunol; 2006 Feb 15; 36(2):411-20. PubMed ID: 16369915
    [Abstract] [Full Text] [Related]

  • 14. Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.
    Roach TI, Kiderlen AF, Blackwell JM.
    Infect Immun; 1991 Nov 15; 59(11):3935-44. PubMed ID: 1937752
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A, Gray PW, Rinderknecht E, Schreiber RD.
    J Exp Med; 1984 Jul 01; 160(1):55-74. PubMed ID: 6330272
    [Abstract] [Full Text] [Related]

  • 16. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
    Bogdan C, Stenger S, Röllinghoff M, Solbach W.
    Eur J Immunol; 1991 Feb 01; 21(2):327-33. PubMed ID: 1900240
    [Abstract] [Full Text] [Related]

  • 17. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
    Murray HW, Spitalny GL, Nathan CF.
    J Immunol; 1985 Mar 01; 134(3):1619-22. PubMed ID: 3918107
    [Abstract] [Full Text] [Related]

  • 18. IL-2. A cofactor for induction of activated macrophage resistance to infection.
    Belosevic M, Finbloom DS, Meltzer MS, Nacy CA.
    J Immunol; 1990 Aug 01; 145(3):831-9. PubMed ID: 2115543
    [Abstract] [Full Text] [Related]

  • 19. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis.
    Dermine JF, Scianimanico S, Privé C, Descoteaux A, Desjardins M.
    Cell Microbiol; 2000 Apr 01; 2(2):115-26. PubMed ID: 11207568
    [Abstract] [Full Text] [Related]

  • 20. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.